Uso de Fampyra® para la mejoría de la marcha en el paciente con esclerosis múltiple y sus repercusiones en la calidad de vida del paciente

Finally, it is concluded, the improvement in gait through the treatment with Fampyra® leads to a positive adaptation of the patient who suffers other problems as well as the ability to perform the daily activities. The GAITRite® system is highly useful in the evaluation of these patients, as it allows systematic, quick and objective measurements of the gait in patients with MS.